News|Articles|July 7, 2026

First Half 2026 Recap: Gastroenterology

Review the biggest gastroenterology news from the first half of 2026, including FDA updates, IBD advances, and key clinical trials.

The first half of 2026 delivered meaningful progress across gastroenterology, highlighted by important regulatory milestones, encouraging late-stage clinical trial results, and continued innovation in inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and pediatric gastrointestinal care.